Job title: Senior Director & Head of Complex In Vitro Models
Dr. Jason Ekert is head of the Complex In Vitro Models (CIVM) group at GlaxoSmithKline. He leads an integrated enterprise strategy for R&D applications of complex human-relevant and translatable complex in vitro models (eg Spheroids, Organoids, Microphysiological systems and bioprinting). He’s the vice-chair for the IQ-MPS affiliate. Dr Ekert received his PhD in Medical Science from Adelaide University in Australia. He performed post-doctoral training at the University of California, Davis and Coriell Institute for Medical Research. Before coming to GlaxoSmithKline Dr Ekert worked for 11 years at Janssen BioThereapeutics in early biotherapeutic drug discovery in target discovery, drug validation and mechanism of action studies applying complex cell-based assays across multiple therapeutic areas.
Panel Discussion: Enhancing 3D Models Adoption in Preclinical & Clinical Studies 10:30 am
• What are the hurdles for the adoption of 3D models for drug development from an industry perspective? • Assessing the route to accelerate clinically validated 3D models to boost confidence • Costs of technology for better ROI – where are we in the Gartner curve? • Establishing pre-competitive collaboration for patient sample sourcing and…Read more
day: Day One
IQ MPS Affiliate Update: A Pharmaceutical Industry Perspective on Advancing MPS Adoption in Drug Discovery 9:30 am
• Evaluate recent 2.0 survey results benchmarking on how pharmaceutical companies are using MPS models • Explore the highlights on MPS manuscripts outlining specific industry requirements for MPS platforms for various context of use (COE) studies • Discuss the engagement with health authorities related to the level of MPS characterization and qualification required for specific…Read more
day: Day One